| Bayada Home Health Care, Inc | |
| 8801 J M Keynes Drive, Charlotte, North Carolina 28262 | |
| (704) 423-9449 | |
| Name | Bayada Home Health Care, Inc |
|---|---|
| Location | 8801 J M Keynes Drive, Charlotte, North Carolina |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 347087 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 28025, 28026, 28027, 28031, 28035, 28036, 28075, 28078, 28079, 28081, 28083, 28103, 28104, 28105, 28106, 28108, 28110, 28112, 28124, 28134, 28138, 28173, 28174, 28202, 28203, 28204, 28205, 28206, 28207, 28208, 28209, 28210, 28211, 28212, 28213, 28214, 28215, 28216, 28217, 28226, 28227, 28262, 28269, 28270, 28273, 28277, 28278 |
| NPI Number | 1023377439 |
| Organization Name | BAYADA HOME HEALTH CARE, INC. |
| Address | 8801 J M Keynes Dr, Suite 350, Charlotte, NC 28262 |
| Phone Number | 704-423-9449 |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
| NPI Number | 1265736250 |
| Organization Name | BAYADA HOME HEALTH CARE, INC. |
| Address | 7621 Little Ave Ste 210, Charlotte, NC 28226 |
| Phone Number | 704-295-1200 |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
| NPI Number | 1285661785 |
| Organization Name | BAYADA HOME HEALTH CARE, INC. |
| Address | 8801 J M Keynes Dr Ste 330b, Charlotte, NC 28262 |
| Phone Number | 704-549-1700 |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
| NPI Number | 1295766111 |
| Organization Name | BAYADA HOME HEALTH CARE, INC. |
| Address | 8801 J M Keynes Dr Ste 305&330a, Charlotte, NC 28262 |
| Phone Number | 704-971-4600 |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
| NPI Number | 1366421554 |
| Organization Name | MECKLENBURG HOME HEALTH, INC. |
| Doing Business As | HOME HEALTH PROFESSIONALS |
| Address | 2221 Edge Lake Dr, Suite 190, Charlotte, NC 28217 |
| Phone Number | 704-423-9449 |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
| NPI Number | 1720014855 |
| Organization Name | BAYADA HOME HEALTH CARE, INC. |
| Doing Business As | BAYADA HABILITATION |
| Address | 8801 J M Keynes Dr Ste 320, Charlotte, NC 28262 |
| Phone Number | 704-688-2500 |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
| Quality Rating: |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.6 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.4 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
| How often the home health team checked patients for depression | 94.4 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.1 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 77.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.1 | 96.4 |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 86.6 | 79.6 |
| How often patients got better at getting in and out of bed | 87.8 | 81.1 |
| How often patients got better at bathing | 88 | 82.3 |
| How often patients’ breathing improved | 81.7 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 95.4 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 83.1 | 75 |
| How often home health patients had to be admitted to the hospital | 15 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 15.7 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 94.3 | 94 |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
The patient survey data of Bayada Home Health Care, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 83 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 83 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 81 | 78 |
News Archive
UnitedHealth Group has announced a three-year, $2.25 million commitment to support the Y's healthy-living initiatives and efforts to prevent obesity and related chronic diseases.
ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMASORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada.
A new study at Rochester Institute of Technology indicates that the incidence of maltreatment, including neglect and physical and sexual abuse, is more than 25 percent higher among deaf and hard-of-hearing children than among hearing youths. The research also shows a direct correlation between childhood maltreatment and higher rates of negative cognition, depression and post-traumatic stress in adulthood.
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
› Verified 2 days ago
Bayada Home Health Care, Inc Location: 8801 J M Keynes Drive, Charlotte, North Carolina 28262 Ratings: Phone: (704) 423-9449 | |
Kindred At Home Location: 11111 Carmel Commons Blvd Ste 350, Charlotte, North Carolina 28226 Ratings: Phone: (704) 543-1167 | |
Brookdale Home Health Charlotte Location: 9300 Harris Corners Pkwy Suite 410, Charlotte, North Carolina 28269 Ratings: Phone: (704) 921-2051 | |
Atrium Health At Home Charlotte Location: 4701 Hedgemore Drive Suite 300, Charlotte, North Carolina 28209 Ratings: Phone: (704) 512-2300 | |
Advanced Home Care Location: 2520 Whitehall Park Drive Suite 950, Charlotte, North Carolina 28273 Ratings: Phone: (704) 831-5000 | |
Kindred At Home Location: 8520 Cliff Cameron Drive Ste 140, Charlotte, North Carolina 28269 Ratings: Phone: (704) 594-9029 |